Aug 23, 2019 · Our research indicated that three factors make Europe’s biotech market attractive to investors: strong hot spots across geographies, modalities, and therapeutic areas; powerhouse research and industry expertise to support basic science and innovation; and an abundance of high-caliber talent.

Mar 24, 2025 · This report provides a comprehensive analysis of the top 20 European biotech companies, detailing their market size, focus areas, innovations, and key collaborations. It also examines broader industry trends, regulatory dynamics, and funding conditions shaping the future of European biotech.

Jul 29, 2021 · Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing. We mapped out 1,382 biotechs based in Europe and nine clusters emerged.

European Biotechnology is the first and foremost information platform reporting on the life sciences in Europe.

EuropaBio is Europe’s largest biotechnology industry group, founded in 1996 to represent the interests of the biotechnology ecosystem across sectors. It has the vision to deliver a healthy, sustainable and competitive global Europe through biotechnology innovation applied across industrial sectors.

Sep 26, 2024 · Here’s a list of 10 European biotech companies likely to make a big splash in the biotech sector. Born out of the venture capital company Flagship Pioneering, Quotient Therapeutics made its $50 million launch late last year.

To meet and balance the needs of our society, our economy and our planet, European companies are developing new processes and technologies that are based on biology. Biotechnology helps the EU to modernise its industry and agriculture, forestry, energy, food and feed sectors.

Mar 2, 2025 · Check EU rules for developing your biotech and biomanufacturing business, find research infrastructures, and scale up your business with access to networks, funding, and market insights.

Oct 30, 2019 · Genetic Engineering & Biotechnology News ranked the European clusters on the basis of five criteria: patents, venture capital, public research funding, number of biotech companies, and jobs. Here’s a look at the top 10.

Discover how Europe leads with a robust tradition of academic excellence and an aggressive push for biotech industry breakthroughs. We analyze the trendsetting moves from European biotech firms, track the emergence of cutting-edge startups, and bring insights on how these developments are supported by strong public-private partnerships.